Bruker’s BRKR strong growth reflects its fundamental commitment to innovate high-value solutions and ongoing portfolio ...
Guillaume Tetard, Bruker Biospin Vice President for Optical and mCT Preclinical Imaging, added: “The X4 POSEIDON is a cutting-edge XRM system with unmatched image quality in its category for ...
Guillaume Tetard, Bruker Biospin Vice President for Optical and mCT Preclinical Imaging, added: "The X4 POSEIDON is a cutting-edge XRM system with unmatched image quality in its category for ...
Guillaume Tetard, Bruker Biospin Vice President for Optical and mCT Preclinical Imaging, added: “The X4 POSEIDON is a cutting-edge XRM system with unmatched image quality in its category for ...
Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...
In its fourth quarter 2024 investor letter, The London Company SMID Cap Strategy emphasized stocks such as Bruker Corporation (NASDAQ:BRKR). Bruker Corporation (NASDAQ:BRKR) focuses on developing ...
Bruker BioSpin is the pioneer in the development of CryoProbe technology for high-resolution NMR with over 1,300 CryoProbes installed at customer sites worldwide during the last 14 years.
(3) Bruker Scientific Instruments (BSI) revenue reflects the sum of the BSI BioSpin, CALID and Nano Segments as presented in our Annual Report on Form 10-K for the year ended December 31 ...
Bruker exceeded both EPS and revenue forecasts for Q4 2024. The company reported a 14.6% year-over-year increase in quarterly revenue. Stock price decreased by 0.77% despite the earnings beat ...
BILLERICA, Mass. (AP) — BILLERICA, Mass. (AP) — Bruker Corp. (BRKR) on Thursday reported fourth-quarter earnings of $13.7 million. The Billerica, Massachusetts-based company said it had profit ...